MG
VYGR icon

Marex Group’s Voyager Therapeutics VYGR Stock Holding History

Marex Group’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Hold
38,322
– – ﹤0.01% 1047
2026
Q1 		$148K Hold
38,322
– – ﹤0.01% 929
2025
Q4 		$151K Hold
38,322
– – ﹤0.01% 874
2025
Q3 		$179K Hold
38,322
– – ﹤0.01% 734
2025
Q2 		$119K Hold
38,322
– – ﹤0.01% 556
2025
Q1 		$130K Buy
38,322
+10,000
+35% +$46.7K ﹤0.01% 609
2024
Q4 		$161K Buy
+28,322
New +$183K ﹤0.01% 574

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marex Group's VYGR Position: Q2 2026 in Review

Marex Group held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 38,322 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

Marex Group first reported a position in VYGR in Q4 2024 and has held it in 7 quarters since. The position peaked at $179K in Q3 2025. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Marex Group held 38,322 shares of Voyager Therapeutics worth $134K as of Q2 2026.
  • Marex Group left its Voyager Therapeutics share count unchanged in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #1047 holding.
  • Marex Group first reported a position in Voyager Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Marex Group's Voyager Therapeutics position peaked at $179K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.